Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood
Open Access
- 1 October 2009
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 147 (2), 246-261
- https://doi.org/10.1111/j.1365-2141.2009.07828.x
Abstract
Umbilical cord blood has rapidly become a valuable alternative stem cell source for allogeneic haematopoietic stem cell transplantation. Extensive research over the last 20 years has established the safety and efficacy of umbilical cord blood transplantation in both children and adults with a variety of malignant and non‐malignant diseases. This research has clearly shown that this stem cell source has several unique characteristics resulting in distinct advantages and disadvantages when compared to transplantation with unrelated bone marrow or peripheral blood stem cells. This article reviews the most recent literature comparing the outcomes after umbilical cord blood transplantation with other alternative stem cell sources.Keywords
This publication has 68 references indexed in Scilit:
- Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignanciesBlood, 2008
- Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomesBlood, 2008
- Reduced-Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related DonorTransplantation and Cellular Therapy, 2008
- Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndromeBone Marrow Transplantation, 2007
- Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseasesBone Marrow Transplantation, 2007
- Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic diseaseBlood, 2007
- Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantationBlood, 2006
- Unrelated donor bone marrow transplantation for the treatment of Fanconi anemiaBlood, 2006
- Cord blood transplant in childhood ALLPediatric Blood & Cancer, 2005
- Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated RecipientsThe New England Journal of Medicine, 1996